ALRN 6924 companion diagnostic - Rein Therapeutics
Alternative Names: ALRN-6924 companion diagnostic - Rein TherapeuticsLatest Information Update: 21 Jan 2025
Price :
$50 *
At a glance
- Originator Aileron Therapeutics
- Developer Rein Therapeutics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer